These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

116 related items for PubMed ID: 26180016

  • 1. Imbalance of tumor necrosis factor-α, interleukin-8 and interleukin-10 production evokes barrier dysfunction, severe abdominal symptoms and psychological disorders in patients with irritable bowel syndrome-associated diarrhea.
    Zhen Y, Chu C, Zhou S, Qi M, Shu R.
    Mol Med Rep; 2015 Oct; 12(4):5239-45. PubMed ID: 26180016
    [Abstract] [Full Text] [Related]

  • 2. Immune activation in patients with irritable bowel syndrome.
    Liebregts T, Adam B, Bredack C, Röth A, Heinzel S, Lester S, Downie-Doyle S, Smith E, Drew P, Talley NJ, Holtmann G.
    Gastroenterology; 2007 Mar; 132(3):913-20. PubMed ID: 17383420
    [Abstract] [Full Text] [Related]

  • 3. Diarrhoea-predominant irritable bowel syndrome: an organic disorder with structural abnormalities in the jejunal epithelial barrier.
    Martínez C, Lobo B, Pigrau M, Ramos L, González-Castro AM, Alonso C, Guilarte M, Guilá M, de Torres I, Azpiroz F, Santos J, Vicario M.
    Gut; 2013 Aug; 62(8):1160-8. PubMed ID: 22637702
    [Abstract] [Full Text] [Related]

  • 4. Monocytes and T lymphocytes contribute to a predominance of interleukin 6 and interleukin 10 in systemic lupus erythematosus.
    Mellor-Pita S, Citores MJ, Castejon R, Yebra-Bango M, Tutor-Ureta P, Rosado S, Andreu JL, Vargas JA.
    Cytometry B Clin Cytom; 2009 Jul; 76(4):261-70. PubMed ID: 19199277
    [Abstract] [Full Text] [Related]

  • 5. Effect of the interleukin 10 polymorphisms on interleukin 10 production and visceral hypersensitivity in Chinese patients with diarrhea-predominant irritable bowel syndrome.
    Zhu SW, Liu ZJ, Sun QH, Duan LP.
    Chin Med J (Engl); 2019 Jul 05; 132(13):1524-1532. PubMed ID: 31205078
    [Abstract] [Full Text] [Related]

  • 6. [Expression of human beta-defensin 2 and tumor necrosis factor-A in colonic mucosae of ulcerative colitis and diarrhea-predominant irritable bowel syndrome].
    Li MR, Jiang K, Zhang QY.
    Zhonghua Yi Xue Za Zhi; 2008 Apr 08; 88(14):957-60. PubMed ID: 18756966
    [Abstract] [Full Text] [Related]

  • 7. Functional bowel symptoms in quiescent inflammatory bowel diseases: role of epithelial barrier disruption and low-grade inflammation.
    Vivinus-Nébot M, Frin-Mathy G, Bzioueche H, Dainese R, Bernard G, Anty R, Filippi J, Saint-Paul MC, Tulic MK, Verhasselt V, Hébuterne X, Piche T.
    Gut; 2014 May 08; 63(5):744-52. PubMed ID: 23878165
    [Abstract] [Full Text] [Related]

  • 8. [The effect of interleukin-7 and interleukin-15 on the production of Th1 and Th2 cytokines by peripheral blood mononuclear cells from patients with tuberculosis].
    Yang XM, Dong DQ, Li C, Yang YH.
    Zhonghua Jie He He Hu Xi Za Zhi; 2006 Jun 08; 29(6):403-6. PubMed ID: 17045026
    [Abstract] [Full Text] [Related]

  • 9. Mucosal cytokine imbalance in irritable bowel syndrome.
    Macsharry J, O'Mahony L, Fanning A, Bairead E, Sherlock G, Tiesman J, Fulmer A, Kiely B, Dinan TG, Shanahan F, Quigley EM.
    Scand J Gastroenterol; 2008 Jun 08; 43(12):1467-76. PubMed ID: 18752146
    [Abstract] [Full Text] [Related]

  • 10. Glutamine Restores Tight Junction Protein Claudin-1 Expression in Colonic Mucosa of Patients With Diarrhea-Predominant Irritable Bowel Syndrome.
    Bertrand J, Ghouzali I, Guérin C, Bôle-Feysot C, Gouteux M, Déchelotte P, Ducrotté P, Coëffier M.
    JPEN J Parenter Enteral Nutr; 2016 Nov 08; 40(8):1170-1176. PubMed ID: 25972430
    [Abstract] [Full Text] [Related]

  • 11. Cytokine and clinical response to Saccharomyces boulardii therapy in diarrhea-dominant irritable bowel syndrome: a randomized trial.
    Abbas Z, Yakoob J, Jafri W, Ahmad Z, Azam Z, Usman MW, Shamim S, Islam M.
    Eur J Gastroenterol Hepatol; 2014 Jun 08; 26(6):630-9. PubMed ID: 24722560
    [Abstract] [Full Text] [Related]

  • 12. The expression and the cellular distribution of the tight junction proteins are altered in irritable bowel syndrome patients with differences according to the disease subtype.
    Bertiaux-Vandaële N, Youmba SB, Belmonte L, Lecleire S, Antonietti M, Gourcerol G, Leroi AM, Déchelotte P, Ménard JF, Ducrotté P, Coëffier M.
    Am J Gastroenterol; 2011 Dec 08; 106(12):2165-73. PubMed ID: 22008894
    [Abstract] [Full Text] [Related]

  • 13. Increased proteasome-mediated degradation of occludin in irritable bowel syndrome.
    Coëffier M, Gloro R, Boukhettala N, Aziz M, Lecleire S, Vandaele N, Antonietti M, Savoye G, Bôle-Feysot C, Déchelotte P, Reimund JM, Ducrotté P.
    Am J Gastroenterol; 2010 May 08; 105(5):1181-8. PubMed ID: 19997094
    [Abstract] [Full Text] [Related]

  • 14. Sensory neuro-immune interactions differ between irritable bowel syndrome subtypes.
    Hughes PA, Harrington AM, Castro J, Liebregts T, Adam B, Grasby DJ, Isaacs NJ, Maldeniya L, Martin CM, Persson J, Andrews JM, Holtmann G, Blackshaw LA, Brierley SM.
    Gut; 2013 Oct 08; 62(10):1456-65. PubMed ID: 22767422
    [Abstract] [Full Text] [Related]

  • 15. Relationship between cognitive appraisals of symptoms and negative mood for subtypes of irritable bowel syndrome.
    Sugaya N, Nomura S.
    Biopsychosoc Med; 2008 Apr 08; 2():9. PubMed ID: 18394202
    [Abstract] [Full Text] [Related]

  • 16. Role of tumor necrosis factor-alpha and interleukin-10 gene polymorphisms in irritable bowel syndrome.
    van der Veek PP, van den Berg M, de Kroon YE, Verspaget HW, Masclee AA.
    Am J Gastroenterol; 2005 Nov 08; 100(11):2510-6. PubMed ID: 16279907
    [Abstract] [Full Text] [Related]

  • 17. Predictive factors of irritable bowel syndrome improvement: 1-year prospective evaluation in 400 patients.
    Mearin F, Badía X, Balboa A, Benavent J, Caballero AM, Domínguez-Muñoz E, Garrigues V, Piqué JM, Roset M, Cucala M, Figueras M, RITMO Group.
    Aliment Pharmacol Ther; 2006 Mar 15; 23(6):815-26. PubMed ID: 16556184
    [Abstract] [Full Text] [Related]

  • 18. Association of interleukin-18 expression with enhanced levels of both interleukin-1beta and tumor necrosis factor alpha in knee synovial tissue of patients with rheumatoid arthritis.
    Joosten LA, Radstake TR, Lubberts E, van den Bersselaar LA, van Riel PL, van Lent PL, Barrera P, van den Berg WB.
    Arthritis Rheum; 2003 Feb 15; 48(2):339-47. PubMed ID: 12571842
    [Abstract] [Full Text] [Related]

  • 19. Relationship between subtypes of irritable bowel syndrome and severity of symptoms associated with panic disorder.
    Sugaya N, Kaiya H, Kumano H, Nomura S.
    Scand J Gastroenterol; 2008 Feb 15; 43(6):675-81. PubMed ID: 18569984
    [Abstract] [Full Text] [Related]

  • 20. Sex differences in the symptoms and psychological factors that influence quality of life in patients with irritable bowel syndrome.
    Tang YR, Yang WW, Wang YL, Lin L.
    Eur J Gastroenterol Hepatol; 2012 Jun 15; 24(6):702-7. PubMed ID: 22382707
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 6.